[Janssen] Medical Affairs Director, Solid Tumor Department
- The Director of Medical Affairs, Solid Tumor will lead a multifaceted critical function for the operating company by supporting multiple products across multiple therapeutic areas (TAs), reporting to the Senior Director, Oncology, Medical Affairs Japan. A strong insight into the Solid Tumor (prostate cancer, lung cancer and bladder cancer) therapeutic areas and knowledge of the Japan market is required.
- The position will be part of the Medical Affairs Leadership Team.
- The Director will be an expert in medical strategy development (Medical Affairs Plan, Business Plan, Integrated Evidence Generation Plan) and will lead a group of TA/DA Leads to develop overall strategy for prostate cancer, lung cancer and bladder cancer under his/her supervision with a goal to address medical and scientific issues and to ensure the appropriate use of all relevant Janssen Medical Affairs supported products.
- Identify and devise strategies to address crucial gaps using critical relationships across Medical Affairs, Regional & Global Medical Affairs, R&D, Business Units, IMAT, and others.
- Responsible and accountable for Medical Affairs strategy of therapeutic areas (TAs) including compounds/product development/business plans.
- Lead TA/DA Leads to supervise and ensure the smooth execution of all the medical and scientific activities including evidence generation.
- Lead Oncology Clinical Expert (OCE) who is in charge of early detection and management of adverse events due to our products.
- Collaborate with internal and external stakeholders including key opinion leaders and patient associations to develop and implement the overall Medical Affairs strategy for new and developing products aligned with company brand strategy.
- Oversee development and implementation of Advisory Board strategy and maintain relationships with external investigators and opinion leaders.
- Ensure development of publications arising from Medical Affairs studies and works with relevant teams on broader communication strategy.
- Manage operational budget and allocating human resources upon Medical Affairs plan.
- Responsible for people management and budget management of three TA departments (prostate cancer, lung cancer and bladder cancer) and OCE.
- Responsible for ensuring that all Medical Affairs activities are compliant with Japan Legislation and HCC rules.
- The position is based in Tokyo, Japan
40%：Develop and implement medical strategy
20%：Partner with key internal and external experts on identifying scientific gaps and data generation / communication opportunities.
30% ：Supervise and mentor team as well as hiring
10%：Support the development of broad future MA strategy
Developing TA strategy including Medical Affairs Plan, Business Plan and Integrated Evidence Generation Plan:
- Provides input into early development through the cross functional leadership team (R&D, Medical Affairs, BU, Market Access, etc).
- Assigning members for product development teams (JCoT) for responsible TAs.
- Provides input into brand strategy for respective BUs.
Leading members in TA departments
- Accomplishing TA objectives by establishing plans and KPI measurements with functional directors.
Activities and initiatives to improve work environment, DE&I (diversity, equity and inclusion) and promote talent development.
Required Minimum Education : MD or PhD considered
Other: development of medical strategy, experience in evidence generation, publications, or equivalent academic or clinical experience.
Required Years of Related Experience: 10 years, at least 5 years in relevant position in pharmaceutical industry. Work experience of 2-3 years as a people manager in MA, R&D, and MKT of pharmaceutical industry.
Required Knowledge, Skills and Abilities :
- Strong track record in developing and implementing clinical research and medical strategies including evaluation of value-oriented research and communication strategies.
- Deep understanding of local regulatory policy and industryʼs code of practice related to drug registration, pharmaceutical promotion and clinical study is preferred.
- Business level of Japanese and Professional Level English communication
- Interpersonal flexibility to effectively interact with a broad range of personnel in a cross-functional team environment.
- Presentation skills and business acumen as a necessity
- Demonstrated ability to analyze complex business situations and identify trends and creative business solutions.
- Awareness of, and adherence to, Johnson & Johnson Credo values and International Health Care Business Integrity Guide
- Strong leadership as line Manager or team leader. (Empowerment and influence to the team.)
Preferred Area of Study: good understanding of relevant medical areas
Preferred Related Industry Experience (if applicable): 10 years
Preferred Knowledge, Skills and Abilities :
MD, knowledge and skills for evidence generation
Key Working Relationships
Internal : Janssen Japan MAF all department leaders, HEM BU (including Sales and marketing), Health economics, New Product Planning, PR and Government Affairs, IMAT, R&D, Compliance, Legal, CISO & CE, procurement, finance, HR.
External : KOLs, PMDA, medical societies leaders, population health decision makers, patient associations.
Johnson & Johnson Family of Companies in Japan strongly recommends prospective employees to complete the COVID-19 vaccination before or as soon as after joining our company to prevent the spread of infection among our employees and people around them as well as our customers and the community we serve, and to ensure our responsibilities are sustainably fulfilled as a healthcare company (except for those who cannot vaccinated with underlying medical conditions and other circumstances).